BioCryst Pharmaceuticals
BCRX
#4741
Rank
HK$17.14 B
Marketcap
HK$67.09
Share price
3.14%
Change (1 day)
18.92%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Net assets

Net assets on the balance sheet as of June 2026 : -HK$3.57 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has -HK$3.57 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BioCryst Pharmaceuticals - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-HK$0.93 Billion-74.91%
2024-12-31$-HK$3.7 Billion3.86%
2023-12-31$-HK$3.56 Billion54.56%
2022-12-31$-HK$2.31 Billion175.91%
2021-12-31$-HK$0.84 Billion458.68%
2020-12-31$-HK$0.15 Billion-150.12%
2019-12-31$HK$0.29 B-22.73%
2018-12-31$HK$0.38 B-41.09%
2017-12-31$HK$0.65 B5248.41%
2016-12-31$HK$12.23 M-96.69%
2015-12-31$HK$0.36 B-36.95%
2014-12-31$HK$0.58 B-6818.98%
2013-12-31$-HK$8.74 Million148.12%
2012-12-31$-HK$3.52 Million-103.06%
2011-12-31$HK$0.11 B-77.44%
2010-12-31$HK$0.50 B-23.79%
2009-12-31$HK$0.66 B86.44%
2008-12-31$HK$0.35 B-29.11%
2007-12-31$HK$0.50 B207.58%
2006-12-31$HK$0.16 B-63.69%
2005-12-31$HK$0.45 B98.76%
2004-12-31$HK$0.22 B3.38%
2003-12-31$HK$0.22 B-29.54%
2002-12-31$HK$0.31 B-29.36%
2001-12-31$HK$0.44 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
HK$92.15 B-2,685.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$178.60 B-5,110.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
HK$11.98 B-436.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$16.57 B-564.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-HK$1.5 Billion-58.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$5.60 B-257.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
HK$71.83 M-102.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
HK$85.97 M-102.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$2.67 B-175.15%๐Ÿ‡บ๐Ÿ‡ธ USA